These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 354423)

  • 21. Historical overview of antenatal steroid use.
    Avery ME
    Pediatrics; 1995 Jan; 95(1):133-5. PubMed ID: 7770291
    [No Abstract]   [Full Text] [Related]  

  • 22. The use of exogenous maternal glucocorticoids to prevent neonatal respiratory distress syndrome (RDS)--the state of the facts.
    Zachman RD
    Wis Med J; 1976 Sep; 75(9):S91-2. PubMed ID: 969558
    [No Abstract]   [Full Text] [Related]  

  • 23. Betamethasone vs dexamethasone for the prevention of morbidity in very-low-birthweight neonates.
    Feldman DM; Carbone J; Belden L; Borgida AF; Herson V
    Am J Obstet Gynecol; 2007 Sep; 197(3):284.e1-4. PubMed ID: 17826422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [RDS--no longer an idiopathic respiratory disease].
    Arvidson G; Ekelund L; Astedt B
    Lakartidningen; 1976 Sep; 73(38):3101-4. PubMed ID: 987519
    [No Abstract]   [Full Text] [Related]  

  • 25. [Antenatal corticosteroid therapy].
    Kari A
    Duodecim; 2002; 118(4):329-30. PubMed ID: 12233037
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of hormones on fetal lung development.
    Bizzarro MJ; Gross I
    Obstet Gynecol Clin North Am; 2004 Dec; 31(4):949-61, xii. PubMed ID: 15550344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
    Modanlou HD; Beharry K; Padilla G; Iriye B
    J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antenatal prevention of respiratory distress syndrome; a multicentre survey.
    Luerti M; Bevilacqua G; Volante E; Angiolillo M; Tomassini A; Gaioni L; Ziino L; Vignali M; Conti M
    Eur Respir J Suppl; 1989 Mar; 3():53s-56s. PubMed ID: 2662996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surfactant sufficiency for immature infants--prenatal induction vs. postnatal treatment.
    Taeusch HW; Smith BT
    Eur J Respir Dis Suppl; 1987; 153():249-54. PubMed ID: 3480820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antepartum prevention of respiratory distress syndrome (hyaline membrane disease).
    Sahu S
    J Iowa Med Soc; 1976 Dec; 66(12):481-3, 485-6. PubMed ID: 1036747
    [No Abstract]   [Full Text] [Related]  

  • 31. Glucocorticoids and the respiratory distress syndrome.
    Johnson JW; Beck JC; Haberkern CM
    Obstet Gynecol Annu; 1984; 13():99-129. PubMed ID: 6371622
    [No Abstract]   [Full Text] [Related]  

  • 32. Requirements of perinatal prevention and treatment of respiratory distress syndrome.
    Di Renzo GC; Anceschi MM; Guidetti R; Cosmi EV
    Eur Respir J Suppl; 1989 Mar; 3():68s-72s. PubMed ID: 2662998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Medical prevention of respiratory distress syndrome].
    Lorenz U; Jürgens S; Ragosch V; Kipper-Kreissl B; Weitzel H
    Gynakologe; 1991 Aug; 24(4):223-7. PubMed ID: 1937164
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevention of the respiratory distress syndrome of the newborn. Value of antepartum treatment with glucocorticoids].
    Fargier P; Salle B; Baud ; Gagnaire JC; Arnaud P; Magnin P
    Nouv Presse Med; 1974 Jun; 3(25):1595-1597. PubMed ID: 4602249
    [No Abstract]   [Full Text] [Related]  

  • 35. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical application of corticosteroids for acceleration of fetal lung maturity].
    Schutte MF; Treffers PE; Koppe JG; Breur W; Filedt Kok JC
    Ned Tijdschr Geneeskd; 1979 Mar; 123(11):420-7. PubMed ID: 370617
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical aspects of antenatal enhancement of pulmonary maturation.
    Coustan DR
    Clin Perinatol; 1987 Sep; 14(3):697-711. PubMed ID: 3311545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Glucocorticoids and the respiratory distress syndrome in the newborn. A review of the literature].
    Gandibleux-Bergiers MF
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(5):625-37. PubMed ID: 6757311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neonatal mortality and morbidity. Priorities in perinatal care (author's transl)].
    Amiel-Tison C; Grossi SP; Laroche JC; Royon M; Tchobroutsky C; Henrion R
    Arch Fr Pediatr; 1981 Apr; 38(4):281-90. PubMed ID: 7197512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Respiratory distress syndrome: the preventive use of glucocorticoids.
    Haller CC; King CR
    J Kans Med Soc; 1981 Mar; 82(3):98-106. PubMed ID: 6895085
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.